Hosted on MSN
(2nd LD) Celltrion acquires U.S. biopharma plant from Eli Lilly to counter tariff threats
SEOUL, Sept. 23 (Yonhap) -- Celltrion Inc., South Korea's leading biopharmaceutical company, said Tuesday its U.S. subsidiary has signed a deal to acquire a U.S. biopharmaceutical production facility, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback